World's biggest multibillionaire investor group is buying THIS by the tons Most folks have completely missed the fact that there's one group of investors so powerful they're literally buying ONE THING by the tons… Stacking it in their locked vaults on pallets in record numbers.

Find out what it is and see how you can get in with just a few dollars.

MXC Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 8.17%

Insider Buying (Last 12 Months): A$0.00

Insider Selling (Last 12 Months): A$0.00

Argent BioPharma Insider Trading History Chart

Argent BioPharma Share Price & Price History

A^$0.00

+0.30 (1.20%)

As of 03/18/2020 01:00 AM ET

Claim Your Complimentary Bitcoin Reward

From Crypto Swap Profits | Ad

Many have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.

Secure Your Spot Now

Argent BioPharma Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction
5/5/2023	Ross Walker	Insider	Expiry	1,050,000	A$0.01	A$9,450.00
5/6/2022	Roby Zomer	Insider	Buy	819,672	A$0.02	A$18,852.46
11/24/2021	Ross Walker	Insider	Exercise	600,000	A$0.05	A$27,000.00
10/7/2021	Stephen Parker	Insider	Exercise	600,000	A$0.06	A$35,400.00
9/30/2021	Evan Hayes	Insider	Buy	295,000	A$0.06	A$17,700.00
9/9/2021	Nativ Segev	Insider	Issued	2,100,000	A$0.06	A$126,000.00

This Apple-like Innovator is Revolutionizing Healthcare

From Wall Street Star | Ad

AI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.

Click here to learn more about the booming eHealth industry

SEC Filings (Institutional Ownership Changes) for Argent BioPharma (ASX:MXC)

1.24% of Argent BioPharma stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

MGC Pharmaceuticals Limited provides phytomedicines worldwide. The company produces and supplies medicinal cannabis products; and non-cannabis phytomedicines. Its principal product candidates include CimetrA, which is in phase III clinical trial for the symptomatic treatment of early COVID-19; CannEpil, a phase IIb cannabis-based therapy for drug-resistant Epilepsy; and CogniCann that is in phase II clinical trial for the symptomatic relief of Dementia. In addition, the company provides Irnican that is in preclinical phase for the tetrahydrocannabinol, as well as offers ArtemiC and non-pharma products. Further, it offers consulting services, including clinical research services. MGC Pharmaceuticals Limited was founded in 2014 and is based in Subiaco, Australia.

Today's Range

Now: N/A

50 Day Range

MA: N/A

52 Week Range

Now: N/A

Volume

2,156,322 shs

Average Volume

N/A

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

3.70%

Beta

1.03

Who are the company insiders with the largest holdings of Argent BioPharma?: Argent BioPharma's top insider shareholders include:
Roby Zomer (Insider)
Ross Walker (Insider)
Learn More about top insider investors at Argent BioPharma.

Mysterious Gold Leverage Just Announced

From Stansberry Research | Ad